BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 6274365)

  • 21. [Necrolytic migratory erythema in glucagonoma syndrome (author's transl)].
    Kitoh M; Ohyama K; Shigeo ; Arao AT
    Nihon Hifuka Gakkai Zasshi; 1981 Apr; 91(5):559-68. PubMed ID: 6270429
    [No Abstract]   [Full Text] [Related]  

  • 22. Response of glucagonomas to surgical excision and chemotherapy. Report of two cases and review of the literature.
    Reyes-Govea J; Holm A; Aldrete JS
    Am Surg; 1989 Aug; 55(8):523-7. PubMed ID: 2548427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Glucagonoma: evolution and treatment].
    Carvajal C; Azabache V; Lobos P; Ibarra A
    Rev Med Chil; 2002 Jun; 130(6):671-6. PubMed ID: 12194691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Glucagonoma syndrome].
    Tellechea O; Baptista AP
    Acta Med Port; 1988; 1(2):149-52. PubMed ID: 2849866
    [No Abstract]   [Full Text] [Related]  

  • 25. Ultrastructural studies of necrolytic migratory erythema.
    Ohyama K; Kitoh M; Arao T
    Arch Dermatol; 1982 Sep; 118(9):679-82. PubMed ID: 6287944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucagonomas. Ultrastructure and immunocytochemistry.
    Warner TF; Block M; Hafez GR; Mack E; Lloyd RV; Bloom SR
    Cancer; 1983 Mar; 51(6):1091-6. PubMed ID: 6295622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Asymptomatic pancreatic islet cell tumor (glucagonoma): case report].
    Suto A; Takayama S; Miki H; Izumika H; Tanahashi T; Suzuki H; Takeshita T; Ohmiya H; Kijima H
    Nihon Geka Gakkai Zasshi; 1998 Feb; 99(2):124-8. PubMed ID: 9575509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucagonomas of transgenic mice express a wide range of general neuroendocrine markers and bioactive peptides.
    Rindi G; Efrat S; Ghatei MA; Bloom SR; Solcia E; Polak JM
    Virchows Arch A Pathol Anat Histopathol; 1991; 419(2):115-29. PubMed ID: 1678563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Glucagonoma syndrome without diabetes mellitus].
    Mikkelsen CS; Mikkelsen DB; Vestergaard V; Clemmensen O; Nielsen HO; Bygum A
    Ugeskr Laeger; 2008 Nov; 170(47):3876. PubMed ID: 19014744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid resolution of necrolytic migratory erythema after glucagonoma resection.
    Smith AP; Doolas A; Staren ED
    J Surg Oncol; 1996 Apr; 61(4):306-9. PubMed ID: 8628004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proglucagon processing similar to normal islets in pancreatic alpha-like cell line derived from transgenic mouse tumor.
    Powers AC; Efrat S; Mojsov S; Spector D; Habener JF; Hanahan D
    Diabetes; 1990 Apr; 39(4):406-14. PubMed ID: 2156740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical experience in diagnosis and treatment of glucagonoma syndrome.
    Zhang M; Xu X; Shen Y; Hu ZH; Wu LM; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):473-5. PubMed ID: 15313692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Types of pancreatic islet cells and their immunocytochemical identification.
    Erlandsen SL
    Monogr Pathol; 1980; 21():140-55. PubMed ID: 6163978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical aspects of glucagon-producing islet cell tumors.
    Prinz RA; Dorsch TR; Lawrence AM
    Am J Gastroenterol; 1981 Aug; 76(2):125-31. PubMed ID: 6272569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucagonoma syndrome. A clinicopathologic, immunocytochemical, and ultrastructural study.
    Vandersteen PR; Scheithauer BW
    J Am Acad Dermatol; 1985 Jun; 12(6):1032-9. PubMed ID: 2989344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The glucagon syndrome].
    Goldinger G; Aeberhard P
    Helv Chir Acta; 1980 Jun; 47(1-2):199-204. PubMed ID: 6254912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Glucagonoma].
    Tajima Y
    Nihon Geka Gakkai Zasshi; 1984 Sep; 85(9):1039-43. PubMed ID: 6095016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Necrolytic migratory erythema with myelodysplastic syndrome without glucagonoma.
    Technau K; Renkl A; Norgauer J; Ziemer M
    Eur J Dermatol; 2005; 15(2):110-2. PubMed ID: 15757825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dermatitis, glossitis, stomatitis, cheilitis, anemia and weight loss: a classic presentation of pancreatic glucagonoma.
    Povoski SP; Zaman SA; Ducatman BS; McFadden DW
    W V Med J; 2002; 98(1):12-4. PubMed ID: 11941895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Necrolytic migratory erythema: glucagonoma syndrome. Clinical and histological aspects].
    Wilkinson DS
    Ann Med Interne (Paris); 1984; 135(8):654-7. PubMed ID: 6099068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.